title: [Treatment of chronic cardiac insufficiency with coenzyme Q10, results of meta-analysis in controlled clinical trials].
abstract: Meta-analysis applied to eight controlled clinical trials of coenzyme Q10 (CoQ10)-treatment of congestive heart failure revealed a significant improvement a several important cardiac parameters such as ejection fraction (EF), stroke volume (SV), cardiac output (CO), cardiac index (CI) and end diastolic volume index (EDVI). Concerning the improvement in SV and CO the average patient in the CoQ10 group had a higher score than respectively 76% and 73% of the patients in the placebo group. The improvement in CO and SV was also significant when considering of homogeneity. Additional controlled clinical trials seem justified which may strengthen the power of the meta-analyses. However, based on available results, it can not be excluded that CoQ10 may have a future role a adjunctive therapy in a dosage of 100-200 mg/day in the treatment of chronic congestive heart failure.
authors.forename: A M
authors.initials: AM
authors.lastname: Soja
authors.forename: S A
authors.initials: SA
authors.lastname: Mortensen
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D015201:Meta-Analysis as Topic; D014451:Ubiquinone / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D014451:Ubiquinone